Inventor · disambiguated record
Michael Steven Rooney
Also filed as: ROONEY MICHAEL · ROONEY MICHAEL S · ROONEY MICHAEL STEVEN
8 granted patents·11 pending applications·109 citations·filing 1994–2023
85Inventor score
Files withBIONTECH US INC8BROAD INST INC3BioNTech SE2MASSACHUSETTS INST TECHNOLOGY2NEON THERAPEUTICS INC2
Top patents by PatentIndex Score
19 records- 0196US11939637B2Molecular biomarkers for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Mar 26, 2024·3 cites·12 claims
- 0295US10835585B2Shared neoantigensBROAD INST INC·Filed 2016·Granted Nov 17, 2020·26 cites·35 claims
- 0394US10975442B2Molecular biomarkers for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Apr 13, 2021·8 cites·12 claims
- 0491US11183272B2Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cellsBIONTECH US INC·Filed 2020·Granted Nov 23, 2021·5 cites·19 claims
- 0585US5481809ALaser plumb bob and apparatusFiled 1994·Granted Jan 9, 1996·65 cites·20 claims
- 0677US2023405102A1Neoantigens and methods of their useBIONTECH US INC·Filed 2023·Application pending·0 cites
- 0777US2023414735A1Neoantigens and methods of their useBIONTECH US INC·Filed 2023·Application pending·0 cites
- 0875US11650211B2HLA-based methods and compositions and uses thereofNEON THERAPEUTICS INC·Filed 2019·Granted May 16, 2023·2 cites·23 claims
- 0971US2023384320A1Hla-based methods and compositions and uses thereofBIONTECH US INC·Filed 2023·Application pending·0 cites
- 1066US2022199198A1Method and systems for prediction of hla class ii-specific epitopes and characterization of cd4+ t cellsBIONTECH US INC·Filed 2021·Application pending·0 cites
- 1163US2007152004A1Backpad apparatus for use in conjunction with a golf bagROONEY MICHAEL·Filed 2005·Application pending·0 cites
- 1262US2025345416A1Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methodsBioNTech SE·Filed 2023·Application pending·0 cites
- 1362US2020368337A1Shared neoantigensBROAD INST INC·Filed 2020·Application pending·0 cites
- 1462US2024156961A1Tissue-specific antigens for cancer immunotherapyBIONTECH US INC·Filed 2023·Application pending·0 cites
- 1560US12303561B2Protein antigens and uses thereofBIONTECH US INC·Filed 2018·Granted May 20, 2025·0 cites·24 claims
- 1657US2024366754A1Pharmaceutical compositions for delivery of viral antigens and related methodsBioNTech SE·Filed 2022·Application pending·0 cites
- 1753US11965892B2HLA-based methods and compositions and uses thereofBIONTECH US INC·Filed 2018·Granted Apr 23, 2024·0 cites·21 claims
- 1853US2019307868A1Neoantigens and methods of their useNEON THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1936US2019346442A1Improved hla epitope predictionBROAD INST INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Steven Rooney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →